Reishi Powder (Ganogen®)
Ganoderma lucidum. 70% β-glucans. ≥12 ganoderic acid types. Randomized clinical study on immune cell activity.
Request a Sample
Ganoderma lucidum. 70% β-glucans. ≥12 ganoderic acid types. Randomized clinical study on immune cell activity.
Request a SampleGanogen® reishi is produced via submerged liquid fermentation of Ganoderma lucidum, not field harvest. The production method is the primary differentiator. Precision fermentation takes days rather than months, happens in a controlled environment, and produces a standardized β-glucan concentration in every batch. Field-grown mushroom powders are subject to growing condition variability that makes consistent potency difficult to guarantee.
The 70% β-glucan content is the formulator-facing specification. Field-grown mushroom powders typically test at 10–30% β-glucans, sometimes lower, depending on species, substrate, and harvest timing. At 70%, Ganogen® is operating at pharmaceutical-grade standardization levels for a food ingredient.
The ganoderic acid profile (≥12 types) is the triterpene fraction of reishi, the compounds associated with adaptogenic and liver-supportive activity. Qualitative and quantitative profiling of ganoderic acids is part of the production specification.
Ganoderma lucidum. Ganogen® is produced via precision fermentation rather than field harvest, enabling standardized β-glucan concentration across batches.
Ganogen® Reishi is backed by a randomized clinical study conducted in children and adults using reishi in milkshake, yogurt, and supplement formats (2014–2016). Results after supplementation period:
| Immune Marker | Before | After |
|---|---|---|
| Total Leukocytes (cells/μL) | 8,853 | 9,715 |
| CD4+ T-Helper Cells (cells/μL) | 1,498 | 1,622 |
| Immunoglobulin A (IgA, mg/dL) | 287 | 306 |
| Natural Killer (NK) Cells (cells/μL) | 318 | 385 |
| Total Lymphocytes | +16% (Reishi) vs. −10% (Placebo) | |
| CD8 Cytotoxic T Cells | +15.2% (Reishi) vs. −5.3% (Placebo) | |
Ganogen® Reishi is backed by randomized clinical data showing measurable changes in immune cell markers. For supplement brands building immune support claims, clinical backing provides a meaningful substantiation advantage.
| Parameter | Value |
|---|---|
| Species | Ganoderma lucidum |
| Brand name | Ganogen® |
| Production method | Submerged liquid fermentation + spray drying |
| β-Glucan content | 70% |
| Ganoderic acids (triterpenes) | ≥12 types identified |
| Carrier | Maltodextrin |
| Solubility | High (water-soluble) |
| Thermostable | Yes. Survives cooking and baking temperatures. |
| Pack sizes | 1 kg, 5 kg, 20 kg |
| Certifications | Vegan, Organic, Solvent-free, Non-GMO |
Primary application. Backed by randomized clinical data. High β-glucan standardization supports measurable dosing for immune health claims.
Reishi is a foundational adaptogen. Precision fermentation ensures consistent potency in multi-mushroom and multi-adaptogen formulas.
High solubility and thermostability make it suitable for hot and cold beverage applications. Tasteless. Does not alter flavor.
Pairs well with Lion's Mane for combined immune and cognitive positioning. Both are precision-fermented with consistent bioactive profiles.
Thermostable through cooking and baking temperatures. Can be incorporated into bars, baked goods, and snacks without activity loss.
| Document | Availability |
|---|---|
| Certificate of Analysis (COA) | Available upon request |
| Technical Data Sheet (TDS) | Available upon request |
| Clinical Study Summary | Available upon request |
| Allergen Statement | Available upon request |
| Prop 65 Compliance | Available upon request |